万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.viamedica.pl/cardiology_journal
3、投稿网址：
https://journals.viamedica.pl/cardiology_journal/user/newSubmission
4、官网邮箱：editorialoffice@cardiologyjournal.org
5、期刊刊期：双月刊，一年出版6期。
2021年5月27日星期四
投稿须知【官网信息】
Cardiology Journal Guide for Authors
INTRODUCTION
All papers are published in print and online. The official publication date of these papers is the date that they are posted online. Papers published online ahead of print are available on the journal website at https://journals.viamedica.pl/cardiology_journal. Requests for accelerated publication should be explained to the editors in the cover letter.
Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at http://www.icmje.org/recommendations/).
Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information Authors, Readers and Editors may visit the COPE website: http://publicationethics.org/.
EDITORS' CHOICE
Editors' Choice in Cardiology Journal is dedicated to the most valuable and innovative research, comprising methodology and innovations in cardiology, which is of outstanding interest to the readership.
The selection of these articles is based on recommendations from the editors of Cardiology Journal; all manuscripts published in 2016 and forward are eligible to be recommended for Editors' Choice.
ULTRA FAST TRACK
Cardiology Journal offers an UltraFastTrack review (decision within seven days) for manuscripts focused on the following cardiovascular topics:
Methodological papers.
First-in-man studies of novel devices.
Original research on device failure.
Bioengineering models.
Innovation and technology in the pipeline.
The authors interested in applying for an UltraFastTrack review must declare it upfront in the submission process of their manuscript and explain their reasons clearly in the letter to the editors.
NEW: EXPEDITED PUBLICATION DECISION
If you have finalized an original study in the field of interventional cardiology and submitted it earlier for publication, but have not published it yet, Cardiology Journal offers new Expedited Publication Decision.
The Editors-in-Chief of Cardiology Journal, Juan Luis Gutiérrez-Chico MD, PhD, FESC, FACC and Miłosz Jaguszewski MD, FESC are pleased to announce a new Expedited Publication Decision within seven days of receipt of original articles, that are submitted together with an Editor's rejection letter, at least two peer-reviews from a journal with an Impact Factor of 2.0 or greater, responses to the reviewers (Rebuttal letter), highlighted manuscript in track changes mode (indicating the changes that have been made to the reviewers concerns), and a non-highlighted manuscript, all as separate documents. Apart from that, please, indicate in the Cover Letter that this submission concerns expedited review.
We hope this new policy will contribute to the faster visibility of the new research findings.
JOURNAL POLICIES
1. Prior publication
By sending the manuscript with figures and charts the authors declare it has been neither published nor submitted for publication elsewhere (excluding the abstracts 250 words or less). Figures or tables that have been published elsewhere must be identified, and written permission of the original copyright owner must be provided. Such responsibility lies entirely with the authors and the Publisher will not be liable for violation of anyones copyright or other rights by the authors. If the data presented in the article enable identification of the persons, their written consent to the publication must be enclosed.
2. Authorship
All collaborators who have made significant and substantial contributions to a study are considered coauthors. The nature and level of contribution of all authors of accepted manuscripts must be indicated, i.e. conception, design, execution and interpretation of the data being published, wrote the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Other contributions to the work, such as providing of reagents or analytic tools, should be listed in the Acknowledgements. Ghostwriting and guest- authorship are forbidden. In case of detecting ghost written manuscripts, their actions will be taking involving both the submitting authors and the participants involved. The corresponding author must have obtained permission from all authors for the submission of each version of the paper and for any change in authorship. Submission of a paper that has not been approved by all authors may result in immediate rejection. Due to release form the responsibilities to the third parties, corresponding author is required to return to the Publisher a singed copy of the ″Author statement″ together with the manuscript (the ″Author statement″ is available at http://www.cardiologyjournal.org). All authors must agree to the conditions of publication, however the final responsibility for this information lay on the author submitting the manuscript.
3. Conflict of interest
To meet the responsibility to the public to provide clear and unbiased scientific information, all authors must disclose any association that poses a conflict of interest in connection with the manuscript. Authors must indicate any affiliations, funding sources, or financial holdings that might raise questions about possible causes of bias. This information will not be revealed to the reviewers and will not influence the decision concerning the acceptance of the manuscript. After the article is accepted for publication the Editor will discuss with the authors the manner in which the information concerning the financial sources should be provided to the readers. Reviewers and editors are also required to report any conflict of interest in case of recent collaborations with the author (coauthored a paper or worked together on a grant with the author within the past 24 months). Other examples of possible conflicts include a close personal friendship, past or present association as thesis advisor or thesis student, or a family relationship. Additionally, in case of articles presenting drugs or medical equipment, reviewers and editors should disclose to the Editor-in-Chief any financial relations with the corporations manufacturing described drugs and/or equipment.
4. The article should be free of fabrication, falsification, and plagiarism (more information at https://ori.hhs.gov/definition-misconduct).
5. Copyright
Completion of the online submission form electronically is tantamount to automatically and free-of-charge transferring of the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploitation) to the Publisher, under condition that those materials are accepted for publication. The authors agree not to publish any data or figures presented in their work anywhere and in any language without the prior written consent of the owner of the copyrights, i.e. the Publisher.
6. Legal relations
Legal relations between the Publisher and the author(s) are in accordance with Polish law and with international conventions binding to Poland. The legal bases to acquiring the copyright are article 921 section copyright law and related law as well as the international conventions binding to Poland.
7. Human and animal participants and clinical trials.
All research involving ′human and animal participants and clinical trials′ must have the authors institutional review board/local ethical committee approval. Authors are required to include in the Methods section a brief statement identifying the committee approving the experiments. All experiments involving humans must have been conducted according to the principles stated in the Declaration of Helsinki. Authors are obliged to include a declaration confirming that informed consent was obtained from all participants. For animal experimentation reported in the Journal, it is expected that investigators will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing and Education issued by the New York Academy of Sciences Ad Hoc Committee on Animal Research. Adherence to these principles should be indicated in the text of manuscript.
8. Sharing Research Data
This journal encourages you to share data that supports your research publication where appropriate. Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project. If you are sharing data, you are encouraged to cite the data in your manuscript and reference list.
If you have made your research data available in a data repository, you can link your article directly to the dataset thus giving readers access to underlying data that gives them a better understanding of the research described. There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system.
Via Medica recommends the use of Mendeley Data, which enables you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository.
9. Disclaimer
Every effort is made by the Publisher and Editorial Board to ensure that no inaccurate or misleading data, opinion or statement appears in CJ. However, responsibility for the accuracy of statements of fact, the authenticity of scientific findings or observations, expressions of scientific or other opinion and any other material published in the journal rests solely with the author, the respective contributor, sponsor or advertiser. Accordingly, the Publisher and the Editorial Board accept no liability whatsoever for the consequences of any such inaccurate of misleading data, opinion or statement. Every effort is made to ensure that drug doses and other quantities are presented accurately. Nevertheless, readers are advised that methods and techniques involving drug usage and other treatments described in the Journal should only be followed in conjunction with the drug or treatment manufacturer own documentation as published in the country of the reader.
PREPARATION OF MANUSCRPITS
Please submit an accompanying cover letter and author statement with every manuscript (please see forms). Manuscripts should be written in simple, concise and grammatical English, within the size limits specified for each type of article, prepared according to the guidelines below. The main text of the manuscript should be written in a standard PC-compatible word processing program (e.g., Microsoft Word) using Times New Roman font size 12, double-spaced throughout and submit as .doc/.docx or .rtf file. The text must be provided unjustified and auto-hyphenation must be inactivated. Greek and other special characters may be used only by inserting in the text as ″Symbol″ (and not by using ″symbol″ font which may be lost during subsequent file processing. It is advised not to underline in the text and avoid footnotes. When essential, footnotes are numbered consecutively and typed at the foot of the appropriate page. All dimensions and measurements must be specified in the metric system. Particular attention needs to be paid to the selection of appropriate analysis of data and the results of statistical test should be incorporated in the results section. Abbreviations, if used, should be defined in brackets on their first appearance in the text (separately in the abstract and in the main text). The abbreviations that are not accepted by the international groups of experts, should be avoided.
Authors who believe their English language manuscript may require editing to eliminate possible errors and to conform to proper scientific English may wish to use the English language editing service available from one of Cardiology Journal experts at attractive pricing (never exceeding USD 15,00 per manuscript page). In case of such interest, please contact our office at editorialoffice@cardiologyjournal.org
……
更多详情：
https://journals.viamedica.pl/cardiology_journal/about/submissions#authorGuidelines
